Remove 2013 Remove Drug Pricing Remove Prescription Filling
article thumbnail

Three strategies for managing loss of exclusivity successfully

pharmaphorum

Drug prices to plummet in wave of expiring patents”. Price decay after loss of brand exclusivity”. These are just three headlines that come up when you Google “drug patent expiry”. Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. “Patent losses could sink Allergan”.

article thumbnail

ProxsysRx’s MedServRx: The Prescription-Drug Advantage For Patients And Their Providers

Proxsys Rx

The cost of prescription non-adherence to the community at large — which ultimately pays for uncompensated care (particularly for hospital readmissions) — is staggering. In 2013, total overpayments amounted to $135 million in our sample, or $10.51 vs. $13.46). per covered life.”